Please provide your email address to receive an email when new articles are posted on . The monofocal and toric lenses offer quality distance vision and improved depth of focus. TruPlus showed a 3.5 ...

TruPlus is designed to increase depth of focus while maintaining the high-quality distance vision surgeons expect from a monofocal IOL1,2 TruPlus demonstrates higher distance image quality across ...

EXCLUSIVE: The Garfield Movie producer Alcon Media Group wants Parrot Analytics to inform its IP strategy following its acquisition of 108 Village Roadshow Entertainment Group feature films. The ...

CABELL COUNTY, W.Va. (WSAZ) - Alcon is expanding its facility in Lesage with an $81 million investment, which is expected to create 75 jobs. The general manager of the facility, Candace Childers, said ...

Alcon, the world’s largest eye care device company focusing on surgical equipment and vision care products, is investing $81 million at its Greenbottom facility near Lesage to expand manufacturing and ...

Alcon and Lensar are walking away from a proposed acquisition deal following pushback from the Federal Trade Commission (FTC). The U.S. antitrust watchdog had requested additional information about ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an agreement with LENSAR, Inc.

FDA has approved Johnson & Johnson's Tecnis PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract surgery. The new IOL will be available to U.S. patients ...

The 2027 college football recruiting cycle has picked up in the first two months of the 2026 offseason. A handful of the best 2027 prospects decided to get their commitments out of the way well in ...

In the latest quarter, 7 analysts provided ratings for Alcon (NYSE:ALC), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

Milestone includes more than 6 million PCIOL implants worldwide, with PanOptix and Vivity leading globally in trifocal and EDOF IOLs1,* PanOptix delivers outstanding patient satisfaction and freedom ...